What if the painful swallowing, food getting stuck, and persistent heartburn you've been experiencing isn't just “acid reflux” but something much more complex? Eosinophilic esophagitis (EoE) is rapidly becoming one of the most underdiagnosed yet increasingly common conditions I see in my practice. As a functional medicine physician who specializes in autoimmune and inflammatory conditions, I've witnessed firsthand how this condition can transform lives—and how understanding its deep connection to mast cell activation can be the key to true healing.

What is Eosinophilic Esophagitis?

Eosinophilic esophagitis is a chronic immune-mediated inflammatory disorder of the esophagus characterized by symptoms of esophageal dysfunction and at least 15 eosinophils per high-power field on esophageal biopsy. Unlike typical gastroesophageal reflux disease (GERD), EoE is an allergic inflammatory disease driven by food antigens and environmental allergens.

In healthy individuals, eosinophils are normally present in the mucosa of all segments of the digestive tract, except the esophagus. Therefore, the presence of eosinophils in the esophagus is commonly associated with disease and requires careful evaluation.

Key Characteristics of EoE:

• Chronic inflammation: Persistent eosinophilic infiltration of the esophageal tissue
• Food-mediated: Primarily triggered by specific foods, though aeroallergens can also play a role
• Progressive: Can lead to fibrosis, strictures, and permanent structural changes if untreated
• Type 2 immune response: Driven by Th2 cytokines including IL-4, IL-5, and IL-13

The Alarming Rise of EoE: By the Numbers

The statistics surrounding eosinophilic esophagitis are staggering and paint a picture of a condition that's rapidly becoming a significant public health concern:

Current Prevalence and Incidence:

• Overall prevalence: Approximately 1 in 700 Americans now have EoE
• 2022 data: Shows a prevalence of 163 cases per 100,000 in those under 65
• Rapid increase: The incidence and prevalence have increased substantially over the past two decades
• Economic burden: EoE-associated annual costs were estimated to be $1.3 billion in 2024 dollars

Demographic Patterns:

• Male predominance: EoE affects males more frequently than females (approximately 3:1 ratio)
• Age at diagnosis: Average age between 30-50 years, though it can occur at any age
• Geographic distribution: Higher prevalence in industrialized countries with high socioeconomic development
• Peak age groups: Highest prevalence rates in the 18-64 age group (173.9 per 100,000)

Why the Dramatic Increase?

The rise in EoE incidence is outpacing increases in recognition and endoscopy volume, suggesting this isn't simply due to better awareness. Several factors may be contributing to this epidemic:

1. Environmental factors: Changes in food processing, increased environmental allergen exposure
2. Hygiene hypothesis: Decreased early-life microbial exposure affecting immune development
3. Dietary changes: Increased consumption of processed foods and food additives
4. Loss of H. pylori: The decline in H. pylori prevalence may be affecting immune regulation
5. Chemical exposures: Increased exposure to environmental toxins and endocrine disruptors

Who is Affected by EoE?

Primary Demographics:

• Gender: Predominantly affects males (approximately 75% of cases)
• Race/Ethnicity: More common in Caucasians, though this may reflect diagnostic disparities
• Geographic patterns: Higher prevalence in Western, industrialized nations
• Socioeconomic factors: More commonly diagnosed in those with private insurance vs. Medicare/Medicaid

Associated Conditions:

EoE doesn't occur in isolation. Most patients present with a personal allergic background including:

• Asthma: Found in 40-60% of EoE patients
• Allergic rhinitis: Present in 50-75% of cases
• Atopic dermatitis: Common comorbidity
• Food allergies: Often multiple food sensitivities
• Oral allergy syndrome: Cross-reactivity with pollens

Symptoms and Clinical Presentation

The symptoms of EoE can vary significantly between children and adults, often leading to delayed diagnosis:

Adult Symptoms:

• Dysphagia: Difficulty swallowing, the most common symptom
• Food impaction: Food getting stuck in the esophagus (occurring in 46% of adults at diagnosis)
• Chest pain: Non-cardiac chest pain
• Heartburn: Often mistaken for GERD
• Regurgitation: Food coming back up

Pediatric Symptoms:

• Feeding difficulties: Refusal to eat, prolonged feeding times
• Failure to thrive: Poor weight gain
• Vomiting: Frequent regurgitation
• Abdominal pain: Often diffuse and non-specific
• Behavioral issues: Related to eating and mealtimes

The Progression: From Inflammation to Fibrosis

EoE appears to progress from an inflammatory-predominant phenotype (primarily seen in children) to a fibrosis-predominant one (seen in adults). This progression helps explain why:

• Children often present with inflammatory symptoms (pain, heartburn, failure to thrive)
• Adults typically develop mechanical symptoms (dysphagia, food impaction) due to structural changes
• Early intervention is crucial to prevent irreversible fibrotic changes

The Hidden Connection: EoE and Mast Cell Activation Syndrome

Here's where the story gets really interesting—and where functional medicine's systems approach becomes crucial. While mainstream medicine has focused primarily on eosinophils in EoE, emerging research reveals that mast cells play an equally important role in this condition.

The Science Behind the Connection

Recent studies have identified several critical connections between mast cell activation and EoE:

1. Esophageal mastocytosis: EoE patients have significantly increased mast cell density in their esophageal tissue compared to healthy controls
2. Mast cell degranulation: These mast cells are not just present—they're actively degranulating and releasing inflammatory mediators
3. Persistent inflammation: Even when eosinophil counts normalize with treatment, elevated mast cell counts often persist and correlate with ongoing symptoms
4. Barrier dysfunction: Activated mast cells disrupt esophageal epithelial barrier function, making tissues more permeable to allergens

The Inflammatory Cascade

Understanding how mast cells contribute to EoE helps explain why some patients don't respond well to conventional treatments:

The Mast Cell-Eosinophil Loop:

1. Food allergens trigger mast cell activation
2. Mast cells release histamine, cytokines, and inflammatory mediators
3. These mediators attract and activate eosinophils
4. Eosinophils release IL-9, which promotes further mast cell proliferation
5. Both cell types contribute to tissue remodeling and fibrosis

Key Mediators Released by Mast Cells in EoE:

• Histamine: Increases vascular permeability and attracts eosinophils
• IL-4 and IL-13: Drive Th2 immune responses and eosinophil recruitment
• Oncostatin M (OSM): Disrupts epithelial barrier function
• Granulocyte-macrophage colony-stimulating factor: Promotes eosinophil survival
• TNF-α: Drives inflammatory responses

Clinical Implications

This mast cell connection explains several clinical observations:

• Why histamine blockers help: Many EoE patients benefit from H1 and H2 antihistamines
• Persistent symptoms: Patients may continue having symptoms even when eosinophil counts normalize
• Variable treatment response: Some patients need mast cell-targeted therapies in addition to standard EoE treatments
• Environmental triggers: Why stress, temperature changes, and chemical exposures can worsen EoE symptoms

The Mast Cell Activation Syndrome (MCAS) Overlap

Many of my EoE patients also meet criteria for Mast Cell Activation Syndrome (MCAS). This isn't coincidental—it represents a fundamental dysregulation of the immune system that affects multiple organs.

Understanding MCAS

As I've written extensively about in my previous articles on mast cell activation, MCAS is a condition where mast cells become hypervigilant and release inflammatory mediators inappropriately. Key features include:

• Normal numbers of mast cells that are overactive
• Multi-system symptoms affecting various organs
• Episodes triggered by foods, stress, chemicals, and other environmental factors
• Response to mast cell-targeted treatments

For a comprehensive understanding of MCAS, I encourage you to read my detailed articles:

• Mast Cell Activation Syndrome: Here's What You Need to Know When Histamine Goes Haywire
• Mast Cell Activation Syndrome: 9 Powerful Treatments – and a Surprising Newcomer
• Mast Cell Activation Syndrome: How It's Diagnosed and 2 Exciting New Treatments

The EoE-MCAS Connection in Practice

In my clinical experience, patients with both EoE and MCAS typically present with:

• Broader symptom spectrum: Not just esophageal symptoms, but multi-system manifestations
• Environmental sensitivities: Reactions to chemicals, fragrances, and temperature changes
• Histamine intolerance: Reactions to high-histamine foods beyond just their specific food triggers
• Chronic inflammation: Elevated inflammatory markers and poor response to single-target therapies

Why This Matters for Treatment

Recognizing the mast cell component of EoE has profound implications for treatment success. Patients who fail to respond adequately to conventional EoE treatments often benefit from addressing the underlying mast cell activation.

Dr. Jill's Comprehensive EoE Protocol

Based on years of clinical experience and the latest research on the mast cell-EoE connection, I've developed a comprehensive protocol that addresses both the eosinophilic inflammation and the underlying mast cell dysfunction.

Dr. Jill's Protocol for EoE

1. Gut Calm Powder – 1 scoop in water twice daily

• Contains a blend of glutamine, zinc carnosine, and other gut-healing nutrients
• Helps heal the esophageal epithelial barrier
• Reduces inflammation and supports tissue repair
• Purchase Gut Calm Powder

2. Zinc Soothe – 1 capsule twice daily prior to meals

• Provides bioavailable zinc in the form of zinc carnosine
• Essential for epithelial barrier integrity
• Anti-inflammatory properties specific to the GI tract
• Purchase Zinc Soothe

3. Hist Ease – 2 capsules twice daily OR Hist Assist – 2 capsules twice daily

• Natural antihistamines and mast cell stabilizers
• Quercetin, bromelain, and other flavonoids that calm mast cell activation
• Choose based on individual tolerance and response
• Purchase Hist Ease or Purchase Hist Assist

4. Histamine Blocker – 1 capsule prior to meals

• Contains DAO (diamine oxidase) enzyme to break down dietary histamine
• Reduces histamine load from foods
• Essential for those with histamine intolerance component
• Purchase Histamine Blocker

5. Spore Probiotic Complete – 2 capsules daily

• Spore-based probiotics that support immune regulation
• Helps restore healthy gut microbiome balance
• Less likely to cause histamine reactions than traditional probiotics
• Purchase Spore Probiotic Complete

6. Allergen-Free and Low-Histamine Diet (detailed below)

The Therapeutic Diet Approach

Diet is absolutely crucial in managing EoE, but it's not just about eliminating the “big 6” allergens. Based on the mast cell connection, I recommend a more comprehensive approach:

Phase 1: Elimination (4-6 weeks)

Remove the most common EoE trigger foods:

• Dairy: All cow's milk products
• Wheat/Gluten: All gluten-containing grains
• Soy: All soy products
• Eggs: Both egg whites and yolks
• Nuts: Tree nuts and peanuts
• Fish/Shellfish: All seafood

Phase 2: Low-Histamine Protocol

Simultaneously implement a low-histamine diet based on the research showing mast cell involvement:

Dr. Jill's Low-Histamine Diet Guidelines for EoE

FOODS TO ENJOY (Low Histamine):

Proteins:

• Freshly cooked chicken, turkey, lamb (organic preferred)
• Fresh fish (cooked immediately after purchase, not stored)
• Fresh, pure meats without preservatives

Vegetables:

• Leafy greens (lettuce, arugula, bok choy)
• Cruciferous vegetables (broccoli, cauliflower, Brussels sprouts)
• Root vegetables (carrots, beets, sweet potatoes – except regular potatoes)
• Squash varieties (zucchini, yellow squash, butternut squash)
• Fresh herbs (basil, oregano, thyme, rosemary)

Fruits:

• Fresh apples and pears
• Fresh melons (cantaloupe, honeydew, watermelon)
• Fresh stone fruits consumed immediately (peaches, apricots)
• Coconut (fresh or minimally processed)
• Fresh figs

Grains & Starches:

• Rice (white or brown)
• Quinoa
• Millet
• Gluten-free oats (if not eliminating)

Fats & Oils:

• Extra virgin olive oil
• Coconut oil
• Avocado oil
• Fresh avocados

Beverages:

• Pure water
• Herbal teas (chamomile, ginger – if tolerated)
• Fresh vegetable juices from allowed vegetables

FOODS TO AVOID (High Histamine or Histamine-Releasing):

Proteins:

• Aged, cured, or processed meats (salami, pepperoni, hot dogs)
• Leftover cooked meats (histamine increases after cooking)
• Shellfish and canned fish
• Aged cheeses and fermented dairy

Vegetables:

• Tomatoes and tomato products
• Spinach
• Eggplant
• Sauerkraut and fermented vegetables
• Leftover cooked vegetables

Fruits:

• Citrus fruits (oranges, lemons, grapefruits)
• Berries (strawberries, raspberries, blackberries)
• Bananas (especially overripe)
• Grapes and raisins
• Pineapple
• Dried fruits

Beverages:

• Alcohol (all types)
• Coffee (can be histamine-liberating)
• Black and green teas
• Energy drinks

Other Items:

• Fermented foods (kimchi, kombucha, kefir)
• Vinegar and vinegar-containing foods
• Chocolate and cocoa
• Nuts (especially walnuts)
• Food additives and preservatives
• Artificial colors and flavors

Phase 3: Systematic Reintroduction (After 6-8 weeks)

Once symptoms improve, systematically reintroduce foods one at a time:

1. Introduce one food group every 3-4 days
2. Monitor symptoms carefully
3. Keep a detailed food and symptom diary
4. Work with a knowledgeable practitioner to guide the process

Additional Therapeutic Considerations

Stress Management:

• Chronic stress activates mast cells and worsens EoE
• Implement stress-reduction techniques (meditation, yoga, deep breathing)
• Consider adaptogenic herbs if appropriate

Environmental Factors:

• Assess for mold exposure (a major mast cell trigger)
• Minimize chemical exposures (cleaning products, fragrances)
• Address any underlying infections that may be triggering immune activation

Sleep Optimization:

• Poor sleep worsens immune dysfunction
• Aim for 7-9 hours of quality sleep nightly
• Address sleep apnea if present

Monitoring Progress and Long-Term Management

Clinical Markers to Track:

• Symptom diary: Daily tracking of dysphagia, pain, and other symptoms
• Eosinophil count: Follow-up endoscopy with biopsy every 6-12 months
• Inflammatory markers: ESR, CRP, and other systemic inflammation markers
• Nutritional status: Monitor for deficiencies due to dietary restrictions

When to Seek Additional Help:

• Persistent symptoms despite dietary elimination
• New or worsening dysphagia
• Food impaction episodes
• Signs of nutritional deficiencies
• Multi-system symptoms suggesting MCAS

The Future of EoE Treatment

As our understanding of the mast cell connection grows, treatment approaches are evolving. Promising developments include:

• Targeted mast cell therapies: Drugs like dupilumab that target IL-4 and IL-13 pathways
• Personalized medicine approaches: Genetic testing to identify individual susceptibilities
• Microbiome modulation: Probiotics and prebiotics designed specifically for EoE
• Novel anti-inflammatory compounds: Natural products that target both eosinophils and mast cells

Why This Matters: A Personal Note

As someone who has dedicated my career to uncovering the root causes of chronic illness, I find the EoE-mast cell connection both fascinating and hopeful. For too long, patients with EoE have been told that diet elimination and acid-blocking medications are their only options. While these can be helpful, they often don't address the underlying immune dysregulation driving the condition.

By understanding and treating the mast cell component of EoE, we can often achieve better outcomes with fewer restrictions. Patients frequently report not just improvement in their swallowing and digestive symptoms, but overall better energy, mood, and quality of life.

In my practice, I've seen patients who struggled for years with conventional EoE treatments finally find relief when we address their underlying mast cell activation. This is the power of functional medicine—looking at the whole person and the interconnected systems rather than just treating the symptoms.

Related Resources and Further Reading

To deepen your understanding of the conditions discussed in this article, I recommend exploring these additional resources from my blog:

Mast Cell Activation Syndrome:

• Mast Cell Activation Syndrome: Beyond Histamine and Tryptase
• Mold is a Major Trigger of Mast Cell Activation Syndrome
• Hidden Infections and Mast Cell Activation Syndrome: What You Need to Know
• The Surprising Link Between Ehlers-Danlos Syndromes & Mast Cell Activation Syndrome
• Mast Cell Activation Syndrome: Can MCAS Really Be Triggered by Toxic Mold?

Why I Link These Articles: These resources are essential reading because they provide the foundational understanding of how mast cell activation affects multiple body systems. The underlying immune dysregulation and hyperresponsive immune system that drives MCAS is the same process contributing to EoE. Understanding mold exposure, infections, and other triggers helps identify why some people develop both conditions and why addressing these root causes is crucial for healing.

Conclusion: A New Paradigm for EoE

Eosinophilic esophagitis is more than just an allergic reaction to food—it's a complex immune disorder involving both eosinophils and mast cells. As the incidence continues to rise, it's crucial that we expand our understanding beyond traditional approaches.

The connection between EoE and mast cell activation opens up new therapeutic possibilities and offers hope for patients who haven't found relief with conventional treatments. By addressing the underlying immune dysregulation, supporting barrier function, and calming mast cell activation, we can often achieve better outcomes with a more holistic approach.

If you're struggling with EoE, remember that you have options beyond just eliminating foods and taking acid blockers. Working with a knowledgeable functional medicine practitioner who understands the mast cell connection can be life-changing.

The future of EoE treatment lies in understanding these complex immune interactions and treating the whole person, not just the symptoms. That's the essence of functional medicine—and it's why I'm so passionate about sharing this information with you.

Dr. Jill Carnahan is a functional medicine physician, researcher, and author who specializes in autoimmune conditions, environmental toxicity, and complex chronic illness. To learn more about Dr. Jill's approach to EoE and mast cell disorders, visit Dr. Jill Health or schedule a consultation at www.jillcarnahan.com.

References

1. Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155(4):1022-1033.
2. Thel HL, Anderson C, Xue AZ, Jensen ET, Dellon ES. Prevalence and Costs of Eosinophilic Esophagitis in the United States. Clin Gastroenterol Hepatol. 2025;23(2):272-280.
3. Mona R, Hruz P. Epidemiology of Eosinophilic Esophagitis: Really a Novel and Evolving Disease? Inflamm Intest Dis. 2025;10(1):34-40.
4. Abonia JP, Blanchard C, Butz BB, et al. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126(1):140-149.
5. Dellon ES, Cotton CC, Gebhart JH, et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol. 2016;14(1):31-39.
6. Sherrill JD, Kc K, Wu D, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7(3):718-729.
7. Caldwell JM, Shukla HH, Rothenberg ME. Lymphocyte eosinophil-activating chemokine/CCL15 is involved in mediating eosinophilic esophagitis. J Allergy Clin Immunol. 2019;143(6):2328-2334.
8. Bolton SM, Kagalwalla AF, Shanahan L, et al. Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis. Am J Gastroenterol. 2020;115(2):224-233.
9. Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116(2):536-547.
10. Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65(1):109-116.